Coronavirus disease 2019 (COVID-19) is a multi-system disease that causes multiple complications. It is linked to the development of new-onset diabetes or unmasking of underlying diabetes. Despite the uncertain exact mechanism, pancreatic angiotensin-converting enzyme 2 (ACE2) receptor, the main enzyme related to COVID-19 pathophysiology has been implied. COVID-19 vaccine was authorized to help control the rapid spread of COVID-19 disease. We report a case of new-onset diabetes type 2 presenting as hyperosmolar hyperglycemic state (HHS) in a patient after receiving COVID-19 vaccine with some literature review of the potential mechanisms by which COVID-19 may cause new-onset diabetes type 2.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075828 | PMC |
| http://dx.doi.org/10.7759/cureus.14125 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Health-related quality of life in adolescents with myocarditis and pericarditis after BNT162b2 COVID-19 vaccination: Korean national surveillance.
Eur J Cardiovasc Nurs
March 2025
College of Nursing, Chungnam National University, Building N1, Munwharo 266, Jungu, 35015 Daejeon, Korea.
Aims: Concerns have been raised regarding the potential causal relationship between myocarditis and mRNA COVID-19 vaccines. In response, the Korea Disease Control and Prevention Agency actively monitored myocarditis and pericarditis in adolescents who received mRNA COVID-19 vaccines in South Korea. Understanding the long-term health outcomes of these cases is essential for developing evidence-based national health policies.
View Article and Find Full Text PDFAnnual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunity.
Clin Infect Dis
March 2025
Center for Data to Discovery and Delivery Innovation (3DI), San Francisco VA Health Care System, San Francisco, CA, USA.
Background: Current U.S. COVID-19 vaccine recommendations provide guidance for adults to receive at least annual variant-targeted vaccination.
View Article and Find Full Text PDFDevelopment and validation of a questionnaire to measure COVID-19 vaccine hesitancy within the Romanian industrial laborers.
Front Public Health
March 2025
Department of Medical Sociology, University of Medicine, and Pharmacy of Craiova, Craiova, Romania.
The identification and quantification of sources of vaccine hesitancy among industrial workers in Romania have become crucial for developing effective strategies to facilitate the vaccination process. Our study included employees, both with and without comorbidities, who work in industrial companies. The goal was to develop a scale to assess COVID-19 vaccine hesitancy in Romania.
View Article and Find Full Text PDFPublic perception of COVID-19 in Saudi Arabia during the Omicron wave: recommendations for policy improvement.
Front Public Health
March 2025
General Directorate of Prisons Health, Ministry of Interior, Jazan, Saudi Arabia.
Background: The emergence of new SARS-CoV-2 variants makes it difficult to forecast potential epidemiological changes. This study investigates Saudi citizens' perceptions of COVID-19 during the Omicron wave.
Methods: We conducted a cross-sectional study using an online survey and a convenience sample of 746 participants.
Preliminary results and a theoretical perspective of co‑treatment using a miR‑93‑5p mimic and aged garlic extract to inhibit the expression of the pro‑inflammatory interleukin‑8 gene.
Exp Ther Med
April 2025
Department of Life Sciences and Biotechnology, University of Ferrara, I-44121 Ferrara, Italy.
The coronavirus disease-19 (COVID-19) pandemic has been a very significant health issue in the period between 2020 and 2023, forcing research to characterize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences and to develop novel therapeutic approaches. Interleukin-6 (IL-6) and IL-8 are considered significant therapeutic targets for COVID-19 and emerging evidence has suggested that microRNAs (miRNAs/miRs) serve a key role in regulating these genes. MiRNAs are short, 19-25 nucleotides in length, non-coding RNAs that regulate gene expression at the post-transcriptional level through the sequence-selective recognition of the 3'-untranslated region (3'-UTR) of the regulated mRNAs, eventually repressing translation, commonly, via mRNA degradation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!